EquityZen Growth Technology Fund LLC - Series 1374
Raised
$714K
Investors
21
Min Invest
$2,002
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1374 is a Delaware pooled investment fund filed by EquityZen Advisors LLC that raised $714K from 21 investors with a $2K minimum investment under Rule 506(b) and 3(c)(1) exemptions. This is part of the EquityZen platform, which operates a family of 1,889+ series funds providing pre-IPO secondary market access.
This pre-IPO fund follows the standard EquityZen template: 506(b) private placement combined with 3(c)(1) investment company exemption, targeting retail-accessible minimums. The $2K entry point and modest raise size ($714K across 21 investors) are consistent with democratized access to late-stage private company shares.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.